Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aveanna Healthcare HoldingsAVAH 63 EV-to-EBIT is 12.55 as of Jul. 20, 2026, which is 3% above its 10-year median of 12.14. GuruFocus rates AVAH with a GF Score™ of 63/100 and a GF Value™ of $5.18 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 468 Healthcare Providers & Services companies, Aveanna Healthcare Holdings ranks better than 63.25% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Aveanna Healthcare Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was $2,714 Mil.
Aveanna Healthcare Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $273 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aveanna Healthcare Holdings EV-to-EBIT Related Terms
Aveanna Healthcare Holdings EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aveanna Healthcare Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Aveanna Healthcare Holdings's EV-to-EBIT falls into.
Aveanna Healthcare Holdings's current Enterprise Value is $3,423 Mil.
Aveanna Healthcare Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $273 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aveanna Healthcare Holdings (AVAH) has a EV-to-EBIT of 12.55 as of Jul. 20, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aveanna Healthcare Holdings and its competitors. This is near median its historical median of 12.14. According to the industry distribution chart, Aveanna Healthcare Holdings ranks #172 out of 468 companies in the Healthcare Providers & Services industry, placing it in the top 36.8%.
Is Aveanna Healthcare Holdings' EV-to-EBIT too high?
Aveanna Healthcare Holdings' current EV-to-EBIT of 12.55 is near median its 10-year median of 12.14. The Healthcare Providers & Services industry median EV-to-EBIT is 15.86. Aveanna Healthcare Holdings' value of 12.55 is 20.9% below this industry median. Based on the distribution chart, Aveanna Healthcare Holdings ranks #172 out of 468 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Aveanna Healthcare Holdings has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' EV-to-EBIT compare to SNDA and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Aveanna Healthcare Holdings ranks #172 out of 468 companies for EV-to-EBIT. This puts Aveanna Healthcare Holdings in the upper half of its industry. The industry median EV-to-EBIT is 15.86. Aveanna Healthcare Holdings' value of 12.55 is 20.9% below this benchmark. While the company's 10-year median is 12.14 vs. the industry median of 15.86, Aveanna Healthcare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.86, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aveanna Healthcare Holdings's current EV-to-EBIT of 12.55 is 20.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aveanna Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aveanna Healthcare Holdings's current EV-to-EBIT is 12.55, which is near median its own 10-year median of 12.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.18, compared to a current price of $9.69 — trading 87.1% above its estimated fair value. The current EV-to-EBIT is 12.55, which is near median its 10-year median of 12.14 and 20.9% below the Healthcare Providers & Services industry median of 15.86. Aveanna Healthcare Holdings' overall GF Score™ is 63/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current EV-to-EBIT is 12.55 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued.
The current stock price of $9.69 is trading 87.1% above its estimated GF Value™ of $5.18.
GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.
Key valuation signals for AVAH:
EV-to-EBIT: 12.55 (near median its 10-year median of 12.14)
GF Value™: $5.18 vs. price of $9.69 (87.1% above fair value)
Industry Position: 20.9% below the Healthcare Providers & Services median (#172 of 468)
No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
63GF Score
Get the complete analysis for AVAH
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAH has been successfully added to your 
